These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 4452780)
1. Clinical and biochemical studies on obese subjects using fenfluramine. Abdel-Kader MM; Mashaly M; Abdel-Aziz MT J Egypt Med Assoc; 1974; 57(9-10):433-41. PubMed ID: 4452780 [No Abstract] [Full Text] [Related]
2. [The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study]. Haug E; Myklebust R Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2545-9. PubMed ID: 4589598 [No Abstract] [Full Text] [Related]
4. A double-blind clinical trial of fenfluramine. Lele RD; Joshi VR; Nathwani AN Br J Clin Pract; 1972 Feb; 26(2):79-82. PubMed ID: 4552745 [No Abstract] [Full Text] [Related]
5. [Treatment of obesity with fenfluramine (Ponderal)]. Persson I; Andersen UD; Deckert T Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075 [No Abstract] [Full Text] [Related]
6. Action of fenfluramine. Kaufmann NA; Blondheim SH Lancet; 1973 Jan; 1(7794):104. PubMed ID: 4118627 [No Abstract] [Full Text] [Related]
7. Treatment of obesity with fenfluramine. Schindler H; Bielesz G Wien Med Wochenschr; 1975 Jan; 125(5):85-8. PubMed ID: 1124579 [No Abstract] [Full Text] [Related]
8. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients. Follows OJ Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755 [No Abstract] [Full Text] [Related]
9. Fenfluramine-associated hypertension. Mabadeje AF West Afr J Pharmacol Drug Res; 1975 Dec; 2(2):145-52. PubMed ID: 1233823 [TBL] [Abstract][Full Text] [Related]
11. Treatment of obesity with fenfluramine. Persson I; Andersen U; Deckert T Eur J Clin Pharmacol; 1973 Aug; 6(2):93-7. PubMed ID: 4588854 [No Abstract] [Full Text] [Related]
12. A clinical trial of a new fenfluramine preparation (Ponderax PA). Hooper AC Postgrad Med J; 1975; 51 Suppl 1():159-60. PubMed ID: 768960 [No Abstract] [Full Text] [Related]
13. Fenfluramine in the management of obesity. Datey KK; Kelkar PN; Pandya RS Br J Clin Pract; 1973 Oct; 27(10):373-5. PubMed ID: 4601613 [No Abstract] [Full Text] [Related]
14. The anorectic and hypotensive effect of fenfluramine in obesity. Hudson KD J R Coll Gen Pract; 1977 Aug; 27(181):497-501. PubMed ID: 616838 [TBL] [Abstract][Full Text] [Related]
16. [Insulin secretion and hydrocarbon tolerance in essential obesity in women (influence of fenfluramine, phenformin and D-amphetamine)]. Cabezas Cerrato J; Catalán E; Vila T; Fernández-Cruz A Rev Clin Esp; 1973 May; 129(4):337-42. PubMed ID: 4720279 [No Abstract] [Full Text] [Related]
17. A double-blind clinical trial of fenfluramine in the treatment of obesity. Sainani GS; Fulambarkar AM; Khurana BK Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636 [No Abstract] [Full Text] [Related]
18. Relative unresponsiveness of obese diabetic compared to obese non-diabetic subjects to the weight-reducing effect of fenfluramine. Otim MA East Afr Med J; 1977 Feb; 54(2):91-5. PubMed ID: 885093 [No Abstract] [Full Text] [Related]
19. [Pulmonary hypertension following use of fenfluramine for obesity]. Maesen BL; Snijder RJ; Stricker BH Ned Tijdschr Geneeskd; 1994 Dec; 138(50):2500-2. PubMed ID: 7800076 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of fenfluramine in obese Nigerians--clinical, metabolic and hypotensive properties. Adadevoh BK Postgrad Med J; 1975; 51 Suppl 1():158. PubMed ID: 768959 [No Abstract] [Full Text] [Related] [Next] [New Search]